AzTrials
AzTrials

Bicep Tendon RuptureNCT04503421

Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair

A study testing Blood Flow Restriction Therapy in people with Bicep Tendon Rupture, run by Henry Ford Health System at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Bicep Tendon Rupture
What is being tested?
Blood Flow Restriction Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteUnited States
Study dates
15 Aug 2020to 15 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-80
  • Undergoing distal biceps tendon repair

Who cannot join

  • Revision Biceps tendon repair,
  • Irrepairable tendon injury,
  • Biceps repairs with biologic augmentation,
  • Patients with concomitant neurovascular injury,
  • Inability to tolerate BFR treatment,
  • Unable to complete full course of physical therapy,
  • Peripheral vascular disease,
  • History of Venous thromboembolism (VTE)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Health Ford Health System

    Detroit, Michigan, 48202

Other trials in United States

About this study

Official title: Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal: A Prospective Randomized Control Trial

The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to the altered tension-length relationship following surgery. The study will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding distal biceps tear and surgical repair

Being tested
Blood Flow Restriction Therapy
Keywords
blood flow restriction, Rehabilitation, Physical therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow Restriction TherapyOther

    Use of a tourniquet set to 50% of limb occlusion pressure while performing post operative physical therapy

Study groups in NCT04503421
Study groupRoleWhat they receive
BFRExperimentalPatient will use the following rehabilitation protocol while incorporating blood flow restriction therapy: * Post-op weeks 0-6: Passive shoulder and wrist Range of Motion (ROM) only * Sling immobilization with active wrist and shoulder ROM * Active extension of biceps to 30 degrees, No active flexion * 6-9 weeks full active extension in brace * Maintain wrist and shoulder flexibility * Begin rotator cuff/deltoid isometrics, progress active extension in brace * Weeks 9-12: Gently advance ROM to tolerance * Discontinue sling * Begin active flexion and extension against gravity. * Advance strength to light resistance, maintain flexibility/ROM * Weeks 12-6 months: Gradual return to full ROM and pain free o Begin gradual flexion strengthening and advance as tolerated
Receives: Other: Blood Flow Restriction Therapy
Control (no BFR)No interventionpatients will use following rehabilitation protocol without the use of blood flow restriction therapy: * Post-op weeks 0-6: Passive shoulder and wrist Range of Motion (ROM) only * Sling immobilization with active wrist and shoulder ROM * Active extension of biceps to 30 degrees, No active flexion * 6-9 weeks full active extension in brace * Maintain wrist and shoulder flexibility * Begin rotator cuff/deltoid isometrics, progress active extension in brace * Weeks 9-12: Gently advance ROM to tolerance * Discontinue sling * Begin active flexion and extension against gravity. * Advance strength to light resistance, maintain flexibility/ROM * Weeks 12-6 months: Gradual return to full ROM and pain free o Begin gradual flexion strengthening and advance as tolerated

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Strength

    measured via dynamometer (pounds)

    Measured: 1 week post-operatively

  2. Strength

    measured via dynamometer (pounds)

    Measured: 6 weeks post-operatively

  3. Strength

    measured via dynamometer (pounds)

    Measured: 3 months post-operatively

  4. Strength

    measured via dynamometer (pounds)

    Measured: 6 months post-operatively

Secondary outcomes (20)
  1. Range of Motion

    via goniometer (degrees)

    Measured: 1 week post-operatively

  2. Range of Motion

    via goniometer (degrees)

    Measured: 6 week post-operatively

  3. Range of Motion

    via goniometer (degrees)

    Measured: 3 months post-operatively

  4. Range of Motion

    via goniometer (degrees)

    Measured: 6 months post-operatively

  5. Perceived Pain

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

    Measured: 1 week post-operatively

  6. Perceived Pain

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

    Measured: 6 week post-operatively

  7. Perceived Pain

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

    Measured: 3 months post-operatively

  8. Perceived Pain

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

    Measured: 6 months post-operatively

  9. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

    Measured: 1 week post-operatively

  10. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

    Measured: 1 week post-operatively

  11. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

    Measured: 1 week post-operatively

  12. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

    Measured: 6 week post-operatively

  13. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

    Measured: 6 week post-operatively

  14. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

    Measured: 6 week post-operatively

  15. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

    Measured: 3 months post-operatively

  16. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

    Measured: 3 months post-operatively

  17. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

    Measured: 3 months post-operatively

  18. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

    Measured: 6 months post-operatively

  19. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

    Measured: 6 months post-operatively

  20. Patient reported outcome scores

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

    Measured: 6 months post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2020
  2. Study start15 Aug 2020
  3. Primary completion15 Aug 2021
  4. Study completion15 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04503421
Sponsor's protocol ID
Henry - IRB00000253
Status last verified
Dec 2023
First submitted
28 Jul 2020
Last updated
8 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Wernbom M, Augustsson J, Raastad T. Ischemic strength training: a low-load alternative to heavy resistance exercise? Scand J Med Sci Sports. 2008 Aug;18(4):401-16. doi: 10.1111/j.1600-0838.2008.00788.x. Epub 2008 May 3.

    PubMed 18466185
  • Huynh T, Leiter J, MacDonald PB, Dubberley J, Stranges G, Old J, Marsh J. Outcomes and Complications After Repair of Complete Distal Biceps Tendon Rupture with the Cortical Button Technique. JB JS Open Access. 2019 Aug 27;4(3):e0013.1-6. doi: 10.2106/JBJS.OA.19.00013. eCollection 2019 Jul-Sep.

    PubMed 31592499
  • Ohta H, Kurosawa H, Ikeda H, Iwase Y, Satou N, Nakamura S. Low-load resistance muscular training with moderate restriction of blood flow after anterior cruciate ligament reconstruction. Acta Orthop Scand. 2003 Feb;74(1):62-8. doi: 10.1080/00016470310013680.

    PubMed 12635796
  • Takarada Y, Takazawa H, Ishii N. Applications of vascular occlusion diminish disuse atrophy of knee extensor muscles. Med Sci Sports Exerc. 2000 Dec;32(12):2035-9. doi: 10.1097/00005768-200012000-00011.

    PubMed 11128848
  • Clark BC, Manini TM, Hoffman RL, Williams PS, Guiler MK, Knutson MJ, McGlynn ML, Kushnick MR. Relative safety of 4 weeks of blood flow-restricted resistance exercise in young, healthy adults. Scand J Med Sci Sports. 2011 Oct;21(5):653-62. doi: 10.1111/j.1600-0838.2010.01100.x. Epub 2010 Mar 11.

    PubMed 21917016

Questions about this trial

What is this clinical trial studying?

A study testing Blood Flow Restriction Therapy in people with Bicep Tendon Rupture, run by Henry Ford Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Strength (time frame: 1 week post-operatively). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04503421, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in